// App-Quantinova.ai

1144 : IL17-producing γδ T cells promote resistance to CDK4/6 inhibitors in HR+HER2- breast cancer

Researchers

Presenter

  • Giulia Petroni

Principal Investigators

  • Claudia Galassi

  • Aitziber Buque

  • Norma Bloy

  • Takahiro Yamazaki

  • Ai Sato

  • Carlos Jimenez-Cortegana

  • Alexander Kirchmair

  • Chiara Massa

  • Carlos Eduardo De Andrea

  • Belen Navarro

  • Irantzu Serrano

  • Esther Navarro Manzano

  • Francesca Finotello

  • Xi Zhou

  • Elena Garcia-Martinez

  • Maria Rodriguez-Ruiz

  • Barbara Seliger

  • Víctor Sánchez-Margalet

  • Luis De La Cruz-Merino

  • Heather McArthur

  • Silvia Formenti

  • Simon Knott

  • Lorenzo Galluzzi

Medical Centers

  • Clinica Universidad de Navarra, Pamplona, Spain

  • Cedars-Sinai Medical Center, Los Angeles, CA

  • Weill Cornell Medicine, New York, NY

  • Universidad de Sevilla, Sevilla, Spain

  • Martin-Luther-University Halle-Wittenberg, Halle, Germany

  • Medical University Innsbruck, Innsbruck, Austria

  • Hospital Universitario Morales Meseguer, Murcia, Spain

Locations

  • Spain

  • United States

  • Germany

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

Disease

  • Breast cancer

  • Chronic obstructive pulmonary disease

Biomarkers

  • Cyclin-dependent kinase 4

  • Programmed cell death protein 1

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved